Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Hannah Fluhrer, Georg C. Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist, Renate Pichler, Johannes Mischinger, Maximilian Seles, Sebastian Mannweiler, Jasmin Spiegelberg, Thomas Bauernhofer, Philipp J. Jost, Sascha Ahyai, Richard Zigeuner, Martin PichlerGND, Dominik A. Barth
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/101483
ISSN:1758-8359OPAC
Parent Title (English):Therapeutic Advances in Medical Oncology
Publisher:SAGE Publications
Type:Article
Language:English
Year of first Publication:2022
Release Date:2023/01/31
Tag:Oncology
Volume:14
DOI:https://doi.org/10.1177/17588359221134065
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für Translationale Krebsforschung
Latest Publications (not yet published in print):Aktuelle Publikationen (noch nicht gedruckt erschienen)
Licence (German):CC-BY-NC 4.0: Creative Commons: Namensnennung - Nicht kommerziell (mit Print on Demand)